Development and validation of a predictive model for new HIV infection screening among persons 15 years and above in primary healthcare settings in Kenya: a study protocol.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 40846507.
- Also identified by DOI 10.1136/bmjhci-2024-101419 and PMC identifier 12374640.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study seeks to determine incidence, comorbidities and drivers for new HIV infections to develop, test and validate a risk prediction model for screening for new cases of HIV. The study has two components: a cross-sectional study to develop the prediction model using the HIV dataset from the Kenya AIDS and STI Control Programme and a 15-month prospective study for the validation of the model. Inferential analysis will be conducted using algorithms that perform best in disease prediction: Extreme Gradient Boosting (XGBoost) and Multilayer Perceptron. Model sensitivity and specificity will be examined using the receiver operating characteristic curve, and performance will be evaluated using metrics: accuracy, precision, recall and F1 score. The study obtained ethical approval (JKU/ISERC/02321/1421) from the Jomo Kenyatta University of Agriculture and Technology Ethical and Research Board and a research licence (NACOSTI/P/24/414749) from the National Commission for Science, Technology and Innovation.
Medical subject headings
- HIV Infections
- Primary Health Care
- Mass Screening